Showing results (11-20 of 109) with videos related to
Sort By:
Pageof 11
Clinical Biochemistry|September 10, 1999
Homogeneous HDL-cholesterol assay versus ultracentrifugation/dextran sulfate-Mg2+ precipitation and dextran sulfate-Mg2+ precipitation in healthy population and in hemodialysis patientsE Bairaktari, M Elisaf, A Katsaraki, et al.Hippokratia|July 16, 2016
No effect of switching to high-dose rosuvastatin, add-on nicotinic acid, or add-on fenofibrate on serum vitamin D levels in patients with mixed dyslipidemiaE S Makariou, M Elisaf, A Kei, et al.Hippokratia|October 1, 2016
Proton pump inhibitors and statins: a possible interaction that favors low-density lipoprotein cholesterol reduction?F Barkas, M Elisaf, C V Rizos, et al.International Journal of Clinical Practice|October 15, 2011
Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistanceE Moutzouri, E Liberopoulos, D P Mikhailidis, et al.Current Medical Research and Opinion|July 24, 2001
The treatment of coronary heart disease: an update. Part 1: An overview of the risk factors for cardiovascular diseaseM ElisafIdrugs : the Investigational Drugs Journal|August 19, 2005
Multiple risk factors in cardiovascular disease--fifth international symposium. 28-31 October 1999, Venice, ItalyM ElisafDiabetes & Metabolic Syndrome|June 18, 2018
SGLT2 inhibitors and the kidney: Effects and mechanismsV Tsimihodimos, T D Filippatos, M S ElisafJournal of the Neurological Sciences|January 6, 2000
Syndrome of inappropriate antidiuresis associated with multiple sclerosisG Liamis, M ElisafDiabetes & Metabolic Syndrome|August 23, 2017
SGLT2 inhibitors-induced electrolyte abnormalities: An analysis of the associated mechanismsT D Filippatos, V Tsimihodimos, G Liamis, et al.Postgraduate Medical Journal|April 1, 1995
Fractional excretion of potassium in normal subjects and in patients with hypokalaemiaM Elisaf, K C SiamopoulosPageof 11